Resitu: minimally invasive surgical technology

Håkan Sjunnesson

Investor, Chair of several growth companies including Paradox Interactive AB, Coolstuff AB, Qvalia Group AB, Emerse AB and Aktivbo Group AB. Member of the board in NuvoAir AB, Novoaim AB and Dalex AB. Previous assignments include Investment Manager Spiltan Invest AB, Managing Partner Nordic Countries Monitor Group, Vice President & Country Manager Gemini Consulting.

Published 2022-06-07

Resitu

Resitu Medical AB
Rapsgatan 7B
Uppsala, Sweden

info@resitumedical.com

Resitu Medical AB is a Swedish Medical Device company founded in 2019. The company is developing instruments enabling safe removal of intact tissues by a revolutionary technology. The solution has the potential to create a paradigm shift in the management of breast cancer. The portfolio of instruments will speed up the process of cancer management using a minimally invasive approach and facilitating the way radiologists and surgeons work.

By using this website, you agree to our use of cookies. We use cookies to provide you with a great experience and to help our website run effectively.